Colony Family Offices’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1K Hold
14,729
– – ﹤0.01% 61
2026
Q1
$16.8K Hold
14,729
– – ﹤0.01% 62
2025
Q4
$18.6K Hold
14,729
– – ﹤0.01% 65
2025
Q3
$22.8K Hold
14,729
– – 0.01% 68
2025
Q2
$19.4K Hold
14,729
– – 0.01% 65
2025
Q1
$24.4K Hold
14,729
– – 0.01% 63
2024
Q4
$21.7K Hold
14,729
– – 0.01% 67
2024
Q3
$21.9K Hold
14,729
– – 0.01% 58
2024
Q2
$18.4K Hold
14,729
– – 0.01% 60
2024
Q1
$17.7K Hold
14,729
– – 0.01% 68
2023
Q4
$22.2K Hold
14,729
– – 0.01% 66
2023
Q3
$23.6K Hold
14,729
– – 0.01% 41
2023
Q2
$32K Hold
14,729
– – 0.01% 38
2023
Q1
$21.5K Hold
14,729
– – 0.01% 92
2022
Q4
$18.4K Hold
14,729
– – 0.01% 75
2022
Q3
$28K Hold
14,729
– – 0.01% 77
2022
Q2
$37K Hold
14,729
– – 0.02% 65
2022
Q1
$51K Hold
14,729
– – 0.02% 31
2021
Q4
$71K Hold
14,729
– – 0.03% 25
2021
Q3
$54K Hold
14,729
– – 0.03% 17
2021
Q2
$60K Buy
+14,729
New +$57.8K 0.04% 22

Other funds holding OPK

Colony Family Offices's OPK Position: Q2 2026 in Review

Colony Family Offices held its Opko Health (OPK) position steady in Q2 2026 at 14,729 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #61.

Colony Family Offices first reported a position in OPK in Q2 2021 and has held it in 21 quarters since. The position peaked at $71K in Q4 2021. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Colony Family Offices held 14,729 shares of Opko Health worth $22.1K as of Q2 2026.
  • Colony Family Offices left its Opko Health share count unchanged in Q2 2026.
  • Opko Health made up ﹤0.01% of Colony Family Offices's portfolio in Q2 2026, its #61 holding.
  • Colony Family Offices first reported a position in Opko Health in Q2 2021 and has held it in 21 quarters since.
  • Colony Family Offices's Opko Health position peaked at $71K in Q4 2021.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Colony Family Offices's 13F filing for Q2 2026, filed 20 Jul 2026.